NEXGEL, Inc. (NASDAQ:NXGL – Get Free Report) was the target of a significant drop in short interest during the month of November. As of November 30th, there was short interest totalling 42,500 shares, a drop of 59.4% from the November 15th total of 104,800 shares. Based on an average daily volume of 66,900 shares, the short-interest ratio is presently 0.6 days. Currently, 0.8% of the company’s shares are sold short.
NEXGEL Trading Up 12.4 %
Shares of NXGL stock traded up $0.50 on Thursday, reaching $4.49. 542,877 shares of the company’s stock were exchanged, compared to its average volume of 44,051. The company’s fifty day simple moving average is $3.09 and its 200 day simple moving average is $2.69. NEXGEL has a 52 week low of $1.84 and a 52 week high of $4.73. The company has a current ratio of 1.51, a quick ratio of 0.93 and a debt-to-equity ratio of 0.19. The stock has a market capitalization of $30.46 million, a PE ratio of -6.88 and a beta of 0.76.
Institutional Inflows and Outflows
A hedge fund recently raised its stake in NEXGEL stock. Northeast Financial Group Inc. boosted its stake in shares of NEXGEL, Inc. (NASDAQ:NXGL – Free Report) by 168.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 31,848 shares of the company’s stock after purchasing an additional 20,000 shares during the quarter. Northeast Financial Group Inc. owned about 0.50% of NEXGEL worth $82,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 2.21% of the stock is currently owned by institutional investors and hedge funds.
NEXGEL Company Profile
NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.
Read More
- Five stocks we like better than NEXGEL
- What is a support level?
- WallStreetBets: How a Reddit Forum Shook Up Stock Market Dynamics
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Are 2024’s Top Insider Buys a Good Bet for 2025?
- Health Care Stocks Explained: Why You Might Want to Invest
- 4 Social Media Stocks to Soar as TikTok’s Future Hangs in Balance
Receive News & Ratings for NEXGEL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NEXGEL and related companies with MarketBeat.com's FREE daily email newsletter.
